Navigation Links
Reportlinker Adds Global Analgesics Industry
Date:11/16/2010

NEW YORK, Nov. 16, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Analgesics Industry

http://www.reportlinker.com/p098419/Global-Analgesics-Industry.html

This report analyzes the worldwide markets for Analgesics in US$ Million by the following segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others (includes combination drugs)), and External Analgesics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 137 companies including many key and niche players such as Bayer Consumer Care, Johnson & Johnson, McNeil Consumer Healthcare, Novartis International AG, Pfizer, Inc., Reckitt Benckiser Group Plc, and Sanofi Aventis S.A. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

ANALGESICS MCP-5064

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 2

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

1. Internal Analgesics 3

Aspirin 3

Acetaminophen 3

Ibuprofen 4

Others 4

2. External Analgesics 4

2. GLOBAL ANALGESICS MARKET OVERVIEW 5

Pain Therapeutic Market 5

Analgesics Market - Offering Immense Potential 5

Internal Analgesics - The Largest & Fastest Growing Market 5

Liquid Analgesics Register Rapid Growth 6

Neuropathic Pain - Unexplored 6

Ibuprofen Scoring High 6

External Analgesics - Loosing Sheen 6

Topical Analgesics Market: Current Picture 7

Competitive Scenario 7

Global Analgesics Market (2007): Leading Analgesics Brands by

Manufacturer 7

3. PRODUCT OVERVIEW 8

A Brief History 8

Analgesics 8

Definition 8

Types of Pain 8

Acute Pain 8

Chronic Pain 9

Drugs Combating Pain 9

Local Anesthetics 9

Narcotic Opioids 10

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 10

Types of NSAIDS 10

Common NSAIDs 11

Clinical Use... 12

Side Effects... 12

Aspirin 13

The Wonder Drug... 13

PolyAspirin: The Safer and More Potent Polymer Variant of

Aspirin 13

Mode of Action 13

Contraindications 14

Acetaminophen 14

Acetaminophen Protects Heart Muscle 14

Acetaminophen Reduces Incidence of Ovarian Cancer 15

Ibuprofen, Ketoprofen and Naproxen 15

Combination Analgesics 15

Table 1: Opioid Analgesics Market: Percentage Share of Opioid

/ Acetaminophen Combination Products in the Opioid Script

Volume (includes corresponding Graph/Chart) 16

OTC Analgesics: An Overview 16

4. INDUSTRY DYNAMICS 17

Escalating R&D Costs: A Boon or Bane? 17

Timeline of the Drug Approval Process 17

Cox II Crisis Tarnishes Industry Growth 17

Novel Therapies to Propel Opioid and Non-Opioid Therapies 18

Rx-to-OTC Switch 18

Why Consumers Prefer OTC Drugs? 18

Development of Analgesic Tripeptides 18

5. RECENT CLINICAL TRIALS 19

PLx Initiates Clinical Trial For Aspirin-PC 19

Neurodiscovery Receives Approval for NSL-101 Phase II Clinical

Trials 19

6. PRODUCT INTRODUCTIONS/INNOVATIONS 20

Victory Pharma Unveils Naprelan Dose Card 20

Nutra Pharma Commences Online Sales of Cobroxin 20

Nutra Pharma to Introduce Nyloxin Rx 20

Dr Reddy's Rolls Out Finrid 20

MIP Technologies and Supelco Introduce Unique SPE Product 21

Novartis Introduces Voltaren AC Product Line 21

ProEthic Pharmaceuticals Releases Ibudone for Acute Pain

Management 21

Dr. Reddy's Laboratories Introduces Supanac for Acute Pain

Management 21

Teva Pharmaceutical Announces the Launch of Fentanyl

Transdermal System 22

Dr. Reddy's Laboratories Introduces Supanac NSAID Drug 22

7. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE

BUILDER 23

Mallinckrodt Introduces Magnacet™ Tablets for Pain Management 23

Wockhardt to Launch New Painkiller 23

Paladin Labs and Labopharm Introduce Tridural™ 23

Shionogi & Co Introduces OxiNorm Powder 0.5% 23

McNeil Brings Chewable TYLENOL® GoTabs Tablets 23

Barr Unveils Generic Version of ACTIQ® 24

Novartis Launches Voltarol Pain-Eze Emulgel. 24

TheraQuest Launches TQ-1017 24

Mentholatum Company Introduces WellPatch Deep Heat Patch 24

8. PRODUCT APPROVALS 25

Par Pharmaceutical Secures Approval for Marketing Tramadol ER 25

Cipher Acquires Tentative Approval for Tramadol ER Capsules 25

Lannett Receives Approval for Developing Hydromorphone

Hydrochloride Tablets 25

King Pharmaceuticals Receives Approval for Embeda Pain-Relief

Capsules 25

Sangart Secures EC's Orphan Drug Designation for MP4CO 26

Biovail Secures Canadian Approval for Ralivia 26

Elite Pharmaceuticals and PharmaNetwrok Receive FDA Approval 26

9. RECENT INDUSTRY ACTIVITY 27

China Life Insurance Inks Agreement with Sino Biopharmaceutical 27

Azur Pharma Inks Agreement with Elan Pharmaceuticals 27

Pfizer Acquires Wyeth 27

Taisho Pharmaceutical Takes Over OTC Drugs Business of

Bristol-Myers Squibb 27

Piramal Healthcare Acquires Minrad International 28

Biocon Acquires Bulk Pharmaceuticals Unit of Hindujas 28

Abbott Acquires PG110 from PanGenetics 28

Sanofi-aventis Mexico Takes Over Laboratorios Kendrick 28

WraSer Acquires e5 Pharma's Trezix 28

Astellas Acquires Exclusive rights to Pain-Relief Drug from

Neuroges 29

Henan Lingrui Pharma Commences Construction of New Analgesic

Factory 29

Labopharm Europe Enters into Agreement with Merck Sharp & Dohme 29

Cumberland Pharmaceuticals Enters into a Commercialization

Agreement with DB Pharm Korea 29

Cumberland Pharmaceuticals Inks an Exclusive Agreement with

Phebra 30

Mallinckrodt Acquires Rights of Exalgo Extended-Release

Tablets from Neuromed 30

Labopharm Europe and Grunenthal Sign Distribution and Supply

Agreement 30

Timm Medical and Ferring Co-promote Prosed DS in the US 30

Competitive Technologies and Fintrade Medical Ink Sales and

Distribution Agreement 31

Accumetrics and Endotech Ink Exclusive Distribution Agreement 31

Astellas and NeurogesX Sign Distribution and Marketing Agreement 31

Akela Pharma Inks Agreement with Teikoku Seiyaku 31

Medical Nutrition Inks Exclusive Licensing Agreement with DSE

Healthcare 32

Echo Therapeutics Inks a Licensing Deal with Ferndale Pharma 32

Circ Pharma Signs a Development Agreement with Elan 33

Orexo Inks Distribution Agreement with Neopharm 33

Orexo Inks Agreement with NovaMed Pharmaceuticals 33

Pharmos and Reperio Enter into Agreement 33

Caraco Pharmaceutical Launches Oxycodone Hydrochloride Tablet 34

Purdue Pharma Provides Labopharm's RYZOLT 34

Bayer Acquires Sagmel's OTC Business 34

E5 Pharma Receives Approval from FDA 34

Pharmaceutical Associates Receives Approval from FDA 34

Concord Receives New Drug Approvals 35

Hisamitsu Receives Approval for SALONPAs® 35

Johnson & Johnson Submits NDA to FDA 35

Nycomed and Paladin Inks Joint-Promotion Agreement for Tridural 35

Akela Extends Agreement with Janssen 35

Daiichi and Lead Chemical Receives Approval for LoxoninÒ Tape 35

Tokio Marine Capital Acquires Showa Yakuhin Kako 36

Corgenix Collaborates with Randox Laboratories 36

Corgenix Receives EPO Approval for Aspirin Resistance Method 36

IOL to Expand Production Capacity 36

American Oriental Bioengineering Partners with China Aoxing 36

Abraxis Takes Over Shimoda and its Subsidiary Company 36

Church & Dwight Snaps Up Del Pharmaceuticals from Coty 37

Sosei Group Corp Re-Acquires Rights to Commercialize AD 923 37

ProStrakan Group Inks Agreement with Paladin Labs 37

Anika Therapeutics Inks Distribution Agreement with DePuy Mitek 38

Wyeth Acquires ThermaCare Brand from P&G 38

Albemarle Appoints Dr. Reddy's as Distributor of Bulk

Ibuprofen API 38

Competitive Technologies and ELS Join Forces to Distribute

Pain Management Device 39

Altea Therapeutics Partners with Hospira 39

Paladin Inks Co-Promotion Deal with Nycomed 39

AstraZeneca to Divest OTC Portfolio 40

10. CORPORTAE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 41

Ranbaxy Receives Approval from FDA 41

Wockhardt Receives FDA Approval for DPN + APAP 41

Alpharma to Market Flector® Patch in the US 41

Auriga and Mikart Inks Agreement to Market Codein 41

Watson Receives FDA Approval for Oxycodone Hydrochloride and

Ibuprofen 41

Labopharm's Tramadol Receives Approval in Canada 41

Lion Acquires BUFFERIN® Trademark Rights 42

Grunenthal's Extends Licensing Agreement with Ortho-McNeil 42

China Aoxing Pockets LRT 42

Anesiva Inks Joint Venture Agreement Wanbang 42

Beijing Med-Pharm Inks Agreement with Lotus Healthcare 42

LAB International Inks Licensing Agreement with Janssen

Pharmaceutica 43

Three Sixty Pockets Rockford-Montgomery Labs 43

Antares Enters into License and Development Agreement for

Opioid Analgesic 43

Abraxis BioScience Acquires AstraZeneca's Analgesic Brand

Portfolio 43

IntelliPharmaCeutics Inks Agreement with Larasan 43

Ranbaxy and Ethypharm Ink In-licensing Agreement 44

Elite Collaborates with TPN to Co-develop Analgesic Drug 44

Novartis Acquires Hexal Company and Major Stake in Eon Labs . 44

NovaDel Pharma Receives Patent for Buccal Sprays Technology 44

Auxilium Pharmaceuticals Enters into a Licensing Agreement

with PharmaForm 44

EC Sanctions Sale of Elan's Prialt 45

EpiCept Corp. Merges with Maxim Pharmaceuticals, Inc 45

Reckitt Benckiser plc Acquires Boots Healthcare International 45

11. FOCUS ON SELECT KEY PLAYERS 46

Bayer Consumer Care (US) 46

Johnson & Johnson (US) 46

McNeil Consumer Healthcare (Canada) 46

Novartis International AG (Switzerland) 46

Pfizer Inc. (US) 47

Reckitt Benckiser Group Plc (UK) 47

Sanofi Aventis S.A. (France) 47

12. GLOBAL MARKET PERSPECTIVE 48

Table 2: World Recent Past, Current & Future Analysis for

Analgesics by Geographic Region/Country - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 48

Table 3: World Historic Review for Analgesics by Geographic

Region/Country - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 49

Table 4: World 11-Year Perspective for Analgesics by

Geographic Region/Country - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for

Years2005,2010 & 2015(includes corresponding Graph/Chart) 50

Table 5: World Recent Past, Current & Future Analysis for

Internal Analgesics by Geographic Region/ Country - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 51

Table 6: World Historic Review for Internal Analgesics by

Geographic Region / Country - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 52

Table 7: World 11-Year Perspective for Internal Analgesics by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 53

Table 8: World Recent Past, Current & Future Analysis for

Internal Analgesics by Product Segment - Aspirin,

Acetaminophen, Ibuprofen, and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for

Years2007 through 2015 (includes corresponding Graph/Chart) 54

Table 9: World Historic Review for Internal Analgesics by

Product Segment - Aspirin, Acetaminophen, Ibuprofen, and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 55

Table 10: World 11-Year Perspective for Internal Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Aspirin, Acetaminophen, Ibuprofen, and Others Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 56

Table 11: World Recent Past, Current & Future Analysis for

Aspirin by Geographic Region/Country - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 57

Table 12: World Historic Review for Aspirin by Geographic

Region/Country - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 58

Table 13: World 11-Year Perspective for Aspirin by Geographic

Region/Country - Percentage Breakdown of Dollar Sales for US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets for Years 2005,2010& 2015

(includes corresponding Graph/Chart) 59

Table 14: World Recent Past, Current & Future Analysis for

Acetaminophen by Geographic Region/ Country - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years2007 through 2015

(includes corresponding Graph/Chart) 60

Table 15: World Historic Review for Acetaminophen by

Geographic Region/Country - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 61

Table 16: World 11-Year Perspective for Acetaminophen by

Geographic Region/Country - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005,2010 & 2015 (includes corresponding Graph/Chart) 62

Table 17: World Recent Past, Current & Future Analysis for

Ibuprofen by Geographic Region/Country - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 63

Table 18: World Historic Review for Ibuprofen by Geographic

Region/Country - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 64

Table 19: World 11-Year Perspective for Ibuprofen by

Geographic Region/Country - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005,2010 & 2015 (includes corresponding Graph/Chart) 65

Table 20: World Recent Past, Current & Future Analysis for

Other Internal Analgesics by Geographic Region/Country - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years2007 through 2015

(includes corresponding Graph/Chart) 66

Table 21: World Historic Review for Other Internal Analgesics

by Geographic Region/Country - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 67

Table 22: World 11-Year Perspective for Other Internal

Analgesics by Geographic Region/Country - Percentage Breakdown

of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years2005,2010 & 2015 (includes corresponding Graph/Chart) 68

Table 23: World Recent Past, Current & Future Analysis for

External Analgesics by Geographic Region/ Country - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 2015

(includes corresponding Graph/Chart) 69

Table 24: World Historic Review for External Analgesics by

Geographic Region / Country - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2007 (includes

corresponding Graph/Chart) 70

Table 25: World 11-Year Perspective for External Analgesics by

Geographic Region /Country - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for

Years2005,2010 & 2015(includes corresponding Graph/Chart) 71

13. THE UNITED STATES 72

A.Market Analysis 72

Current and Future Analysis 72

Pain Statistics in the US 72

Industry Overview 72

Internal Analgesics 73

Cox-2 Drugs in for Some Trouble 73

Switch to OTC Drugs 73

Table 26: US Analgesics Market (2009): Percentage Share

Breakdown of Leading Manufacturers by Sales (includes

corresponding Graph/Chart) 73

Table 27: US Internal Liquid Analgesics Market (2009):

Percentage Share Breakdown of Leading Brands by Sales

(includes corresponding Graph/Chart) 74

Table 28: US Internal Tablet Analgesics Market (2009):

Percentage Share Breakdown of Leading Brands by Sales

(includes corresponding Graph/Chart) 74

Table 29: Internal Analgesics Market in the US by Retail

Channel (2008): Percentage Share by Value Sales for

Discount Stores, Food/Drug Combination Stores, Chain Drug

Stores, Supermarkets, and Independent Drug Stores

(includes corresponding Graph/Chart) 75

Promotional Strategies for the Internal Analgesics 75

Table 30: Market for Internal Liquid Analgesics in the

U.S. by Retail Channel (2008): Percentage Share by Value

Sales for Supermarkets, Drug Stores, and Discounters

(includes corresponding Graph/Chart) 75

Pediatric Analgesics: The New Kid on the Block 75

External Analgesics 76

Stretching Boundaries 76

Table 31: US External Analgesics Market (2007):

Percentage Share Breakdown of Leading Ten Brands by

Revenues (includes corresponding Graph/Chart) 76

Table 32: External Analgesics Market in the US by Retail

Channel (2008): Percentage Share by Value Sales for Chain

drug stores, Discount stores, Food/drug combination

stores, Independent drug stores, and Supermarkets

(includes corresponding Graph/Chart) 76

Rubs, Patches: Driving the External Analgesics Market 77

Patch Relief Gaining Momentum 77

B.Market Analytics 77

Table 33: US Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 77

Table 34: US Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 78

Table 35: US 11-Year Perspective for Analgesics by Product

Segment - Percentage Breakdown of Dollar Sales for Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets for2005,2010 & 2015(includes

corresponding Graph/Chart) 79

14. CANADA 80

Market Analysis 80

Table 36: Canadian Recent Past, Current & Future Analysis

for Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 80

Table 37: Canadian Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 81

Table 38: Canadian 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 &

2015(includes corresponding Graph/Chart) 82

15. JAPAN 83

A.Market Analysis 83

Current and Future Analysis 83

Competitive Scenario in the Past 83

Table 39: OTC Analgesics Market in Japan (2005): Market

Share of Leading Players by Value - Lion, Arax, Taisho

Pharmaceutical, SS Pharmaceutical, Shionogi, and Others

(includes corresponding Graph/Chart) 83

B.Market Analytics 84

Table 40: Japanese Recent Past, Current & Future Analysis

for Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 84

Table 41: Japanese Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 85

Table 42: Japanese 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 & 2015

(includes corresponding Graph/Chart) 86

16. EUROPE 87

A.Market Analysis 87

Current and Future Analysis 87

By Product Group/Segment 87

European Pain Management Market 87

Generics Restrain Revenue Growth 87

Popular Brands in 2004 88

Table 43: Popular Brands of Pain & Inflammation Medication

in Europe (2004): Percentage Share of Aspirin, Voltaren,

Ibuprofen, Nurofen, Vioxx, Celebre, Tylenol, Aulin, Anadin,

and Paracetamol (includes corresponding Graph/Chart) 88

B.Market Analytics 89

Table 44: European Recent Past, Current & Future Analysis

for Analgesics by Geographic Region/Country - France,

Germany, UK, Italy, Spain, Russia and Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years2007 through 2015 (includes corresponding

Graph/Chart) 89

Table 45: European Historic Review for Analgesics by

Geographic Region/Country - France, Germany, UK, Italy,

Spain, Russia and Rest of Europe Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) 90

Table 46: European 11-Year Perspective for Analgesics by

Geographic Region/Country - Percentage Breakdown of Dollar

Sales for France, Germany, UK, Italy, Spain, Russia and Rest

of Europe Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 91

Table 47: European Recent Past, Current & Future Analysis

for Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 92

Table 48: European Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2007 (includes corresponding

Graph/Chart) 93

Table 49: European 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 94

16a. FRANCE 95

A.Market Analysis 95

Current and Future Analysis 95

Competitive Scenario 95

Table 50: Analgesics Market in France (2005): Market Share

of Leading Players by Value - Bristol-Myers Squibb,

Therapix, Roche, Bayer Group, Wyeth Consumer Healthcare,

and Others) (includes corresponding Graph/Chart) 95

B.Market Analytics 96

Table 51: French Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 96

Table 52: French Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 97

Table 53: French 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 &

2015(includes corresponding Graph/Chart) 98

16b. GERMANY 99

A.Market Analysis 99

Current and Future Analysis 99

Competitive Scenario 99

Table 54: Analgesics Market in Germany (2005): Market Share

of Leading Players by Value - Bayer Group, Boehringer

Ingelheim, Wyeth Consumer Healthcare, and Others (includes

corresponding Graph/Chart) 99

B.Market Analytics 100

Table 55: German Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 100

Table 56: German Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 101

Table 57: German 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 &

2015(includes corresponding Graph/Chart) 102

16c. ITALY 103

A.Market Analysis 103

Current and Future Analysis 103

Competitive Scenario 103

Table 58: Analgesics Market in Italy (2005): Market Share

of Leading Players by Value - Bayer Group, Angelini,

Novartis, Bristol-Myers Squibb, and Others (includes

corresponding Graph/Chart) 103

B.Market Analytics 104

Table 59: Italian Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 104

Table 60: Italian Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 105

Table 61: Italian 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 & 2015

(includes corresponding Graph/Chart) 106

16d. THE UNITED KINGDOM 107

A.Market Analysis 107

Current and Future Analysis 107

An Overview of Analgesics Market in the UK 107

Distribution Scenario 107

Competitive Scenario 108

Table 62: Analgesics Market in the United Kingdom (2005E):

Market Shares of Leading Players by Value - Boots

Healthcare, GlaxoSmithKline, and Others (includes

corresponding Graph/Chart) 108

B.Market Analytics 108

Table 63: UK Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 108

Table 64: UK Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 109

Table 65: UK 11-Year Perspective for Analgesics by Product

Segment - Percentage Breakdown of Dollar Sales for Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets for 2005,2010 &

2015(includes corresponding Graph/Chart) 110

16e. SPAIN 111

A.Market Analysis 111

Current and Future Analysis 111

Competitive Scenario 111

Table 66: Analgesics Market in Spain (2005): Market Share

of Leading Players by Value - Bayer Group, Boehringer

Ingelheim, Bristol-Myers Squibb, Novartis, Boots

Healthcare, and Others (includes corresponding Graph/Chart) 111

B.Market Analytics 112

Table 67: Spanish Recent Past, Current & Future Analysis for

Analgesics by Product Segment - Internal Analgesics

(Aspirin, Acetaminophen, Ibuprofen and Others) and External

Analgesics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 112

Table 68: Spanish Historic Review for Analgesics by Product

Segment - Internal Analgesics (Aspirin, Acetaminophen,

Ibuprofen and Others) and External Analgesics Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006(includes corresponding

Graph/Chart) 113

Table 69: Spanish 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for2005,2010 & 2015

(includes corresponding Graph/Chart) 114

16f. REST OF EUROPE 115

Market Analysis 115

Table 70: Rest of Europe Recent Past, Current & Future

Analysis for Analgesics by Product Segment - Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years2007 through

2015 (includes corresponding Graph/Chart) 115

Table 71: Rest of Europe Historic Review for Analgesics by

Product Segment - Internal Analgesics (Aspirin,

Acetaminophen, Ibuprofen and Others) and External Analgesics

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 116

Table 72: Rest of Europe 11-Year Perspective for Analgesics

by Product Segment - Percentage Breakdown of Dollar Sales

for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen

and Others) and External Analgesics Markets for 2005, 2010 &

2015 (includes corresponding Graph/Chart) 117

17. ASIA-PACIFIC 118

A.Market Analysis 118

Current and Future Analysis 118

The OTC Analgesic Market 118

OTC Analgesics Market in Asia-Pacific (2004): A Comparative

Analysis of the Major Regions - Australia, China and South

Korea 118

B.Market Analytics 119

Table 73: Asia-Pacific Recent Past, Current & Future

Analysis for Analgesics by Product Segment - Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years2007 through

2015 (includes corresponding Graph/Chart) 119

Table 74: Asia-Pacific Historic Review for Analgesics by

Product Segment - Internal Analgesics (Aspirin,

Acetaminophen, Ibuprofen and Others) and External Analgesics

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 120

Table 75: Asia-Pacific 11-Year Perspective for Analgesics by

Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and

Others) and External Analgesics Markets for 2005,2010 &

2015(includes corresponding Graph/Chart) 121

18. LATIN AMERICA 122

Market Analysis 122

Table 76: Latin American Recent Past, Current & Future

Analysis for Analgesics by Product Segment - Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 122

Table 77: Latin American Historic Review for Analgesics by

Product Segment - Internal Analgesics (Aspirin,

Acetaminophen, Ibuprofen and Others) and External Analgesics

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 123

Table 78: Latin American 11-Year Perspective for Analgesics

by Product Segment - Percentage Breakdown of Dollar Sales

for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen

and Others) and External Analgesics Markets for 2005, 2010 &

2015(includes corresponding Graph/Chart) 124

19. REST OF WORLD 125

Market Analysis 125

Table 79: Rest of World Recent Past, Current & Future

Analysis for Analgesics by Product Segment - Internal

Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

and External Analgesics Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 125

Table 80: Rest of World Historic Review for Analgesics by

Product Segment - Internal Analgesics (Aspirin,

Acetaminophen, Ibuprofen and Others) and External Analgesics

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 126

Table 81: Rest of World 11-Year Perspective for Analgesics

by Product Segment - Percentage Breakdown of Dollar Sales

for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen

and Others) and External Analgesics Markets for 2005, 2010 &

2015 (includes corresponding Graph/Chart) 127

20. APPENDIX - POPULAR ANALGESIC BRANDS BY REGION 128

Canada 128

France 128

Germany 129

United Kingdom 130

Leading Analgesics Brands for Children 131

Italy 131

Spain 131

Rest of Europe 132

Asia-Pacific 139

Latin America 143

COMPETITION

Total Companies Profiled: 137 (including Divisions/Subsidiaries - 179)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 47

Canada 5

Japan 8

Europe 62

France 4

Germany 9

The United Kingdom 13

Italy 8

Spain 2

Rest of Europe 26

Asia-Pacific (Excluding Japan) 49

Middle East 6

Africa 2

------------------------------------------

To order this report:Drug and Medication Industry: Global Analgesics Industry

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Top Ten Worlds Leading Pharmaceutical Companies
2. Reportlinker Adds Top Ten Worlds Leading Life Science Intermediates Companies
3. Reportlinker Adds Global Blood Glucose Meters and Strips Industry
4. Reportlinker Adds Global Ambulatory & Bathroom Aids Industry
5. Reportlinker Adds Global Insulin Pumps (External) Industry
6. Reportlinker Adds Global Antibiotics Industry
7. Reportlinker Adds Global Medical Specialty Bags Industry
8. Reportlinker Adds Global Ophthalmic Instrumentation Industry
9. Reportlinker Adds Global Nuclear Medicine Industry
10. Reportlinker Adds U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
11. Reportlinker Adds Proteomics - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  CVS Health (NYSE: ... people living in Santa Clara County, CA ... B on the Santa Clara University campus. CVS Pharmacy ... to protect patients against the disease. Students at Santa ... to get vaccinated. In addition, anyone who has had ...
(Date:2/10/2016)... , Feb. 10, 2016  Oxis International Inc. (OTC/QB: ... OXS-1550, was described as a "clinical trial triumph" after ... went into complete cancer remission. Daniel ... Minnesota Masonic Cancer Center. --> Daniel ... Minnesota Masonic Cancer Center. --> An ...
(Date:2/10/2016)... 2016  LexisNexis® Risk Solutions, a leading provider ... launch of LexisNexis Provider Performance Monitor , ... and optimize the quality and efficiency of provider ... scores. By measuring provider performance through Provider Performance ... better outcomes, improve the patient experience and reduce ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis ... Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning author ... memory. The book’s publication date is March 16, 2016. A free review copy ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... digital self-scheduling readily available to physicians. The integration will enable Allscripts users ... select appointments via Everseat’s free mobile app. , The partnership gives Everseat substantial ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Workrite ... and most versatile series of monitor mounts ever. , “Our goal was to ... and easy to install system that we have ever created.” said Darren Hulsey, Product ...
(Date:2/10/2016)... ... ... Anxiety of older Americans over steep cost increases of prescription drugs is at ... to The Senior Citizens League (TSCL). Since last fall, TSCL has ... costs. “The implications are chilling, particularly for people with chronic health problems,” says ...
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
Breaking Medicine News(10 mins):